Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Is NewcelX (NASDAQ:NCEL) Down 12.27% Pre-Market After a USD 1.55 Million Raise?

NewcelX is a Swiss clinical-stage company developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, with programs including AstroRx for ALS and IsletRx for diabetes. The proceeds, together with current cash and a previously announced USD 25 million equity line, will mainly advance …

Vinay Lochav | 13 November 2026

How Did Newsmax (NYSE:NMAX) Swing to a USD 15.2 Million Profit as Shares Rise 12.07% Pre-Market?

For the nine months ended September 30, 2026, revenue was USD 174.8 million against USD 137.0 million, and net income was USD 15.9 million. The prior-year nine-month net loss was USD 96.5 million, which included USD 79.3 million tied to other corporate matters. Cash …

Vinay Lochav | 13 November 2026

Can Nexera Technologies (NASDAQ:NEXR) Steady After a 23.47% Pre-Market Slide Post Reverse Split?

Nexera, formerly Jeffs' Brands, describes its continuingBusinessas e-commerce, mainly on Amazon, plus homeland security and AI-based products. Under the KeepZone AI deal, the unnamed global aerospace and defense buyer paid USD 1,539,800 in its own securities at closing, up from the USD 1 million …

Vinay Lochav | 13 November 2026

What Is Behind the 14.78% Pre-Market Slide in Nexpu (NASDAQ:DPU) After Its USD 28 Million Raise?

The most relevant recent event is financing. On October 19, 2026, Nexpu (NASDAQ:DPU) closed a private placement of 40 million units to non-US investors at USD 0.70, each unit holding one Class A ordinary share and one warrant. The warrants carry a USD 0.71 …

Vinay Lochav | 13 November 2026

Is a 12.12% Pre-Market Pop in One and One Green Technologies (NASDAQ:YDDL) Real News or Noise?

The company, based in San Rafael, Bulacan in the Philippines, recycles and trades scrap metals including copper and brass alloy ingots, aluminum, tin, zinc and iron. It listed onNasdaqon October 9, 2025 after an IPO that raised USD 11.5 million. For 2025, revenue was …

Vinay Lochav | 13 November 2026

Why Is OpenWorld (NASDAQ:OPNW) Bouncing 9.69% Pre-Market to USD 0.59 After a Steep Slide?

OpenWorld describes itself as a technology-powered digitalAssetsand blockchain company. On October 19, 2026 it announced a definitive agreement to acquire Blocksight Holdings, whose AI agents are meant to automate deal structuring, asset verification, investor onboarding and reporting on its platform. The deal is linked …

Vinay Lochav | 13 November 2026

Is PN Smart Energy (NASDAQ:PN) Up 25.11% Pre-Market Because of Its USD 5.2 Million Share Sale?

The company, formerly Skycorp Solar Group, changed its name to PN Smart Energy, effective June 12, 2026, to reflect a push into independent power production. It describes a focus on clean power stations, critical energy materials and intelligent energy infrastructure, and says it is …

Vinay Lochav | 13 November 2026

Why Is Parabolic Technologies (NASDAQ:PARA) Up 20.06% After a USD 13.5 Million Dilutive Raise?

The warrants carry price resets on the fifth and tenth trading day after issuance, set against the lowest recent trading prices and floors of 50% and 30% of the Nasdaq minimum price. By calculation these dates fall around November 12 and November 19, 2026. …

Vinay Lochav | 13 November 2026

Why Is Park Ha Biological Technology (NASDAQ:BYAH) Up 10.86% Pre-Market With No Fresh News Found?

The company develops skincare products in China under the Park Ha brand, with a Product Sales segment and aFranchiseService segment, selling through its own stores and franchisees. It listed onNasdaqin December 2024. In June 2026 it announced an AI-driven skincare tie-up with aSubsidiaryof Star …

Vinay Lochav | 13 November 2026

What Is Behind Pasithea Therapeutics (NASDAQ:KTTA) Rising 9.83% Pre-Market After FDA Clearance?

The company is a clinical-stage biotech whose lead candidate, PAS-004, blocks the MEK pathway, which is overactive in neurofibromatosis type 1. An IND clearance means the FDA allowed the trial to begin; it does not show that the drug works. The application drew on …

Vinay Lochav | 13 November 2026
Support

Hi! How can we help you today?

Loading…